Owen MJ - Search Results

1

Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.

Kehoe P, Williams J, Lovestone S, Wilcock G, Owen MJ. Kehoe P, et al. Among authors: owen mj. Lancet. 1996 Apr 27;347(9009):1185. Lancet. 1996. PMID: 8609781 No abstract available.

2

Presenilin-1 polymorphism and Alzheimer's disease.

Owen MJ, Kehoe P, Williams J. Owen MJ, et al. Lancet. 1996 Aug 10;348(9024):414. doi: 10.1016/s0140-6736(05)65041-6. Lancet. 1996. PMID: 8709769 No abstract available.

3

Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease.

Kehoe P, Williams J, Holmans P, Liddell M, Lovestone S, Holmes C, Powell J, Neal J, Wilcock G, Owen MJ. Kehoe P, et al. Among authors: owen mj. Neuroreport. 1996 Sep 2;7(13):2155-8. doi: 10.1097/00001756-199609020-00019. Neuroreport. 1996. PMID: 8930979

4

Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia.

Williams J, McGuffin P, Nöthen M, Owen MJ. Williams J, et al. Among authors: owen mj. Lancet. 1997 Apr 26;349(9060):1221. doi: 10.1016/s0140-6736(05)62413-0. Lancet. 1997. PMID: 9130948 No abstract available.

5

Case-control study of presenelin-1 intronic polymorphism.

Williams J, Kehoe PG, Owen MJ. Williams J, et al. Among authors: owen mj. J Neurol Neurosurg Psychiatry. 1999 Jun;66(6):702. doi: 10.1136/jnnp.66.6.702. J Neurol Neurosurg Psychiatry. 1999. PMID: 10329741 Free PMC article. No abstract available.

6

Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group.

Williams J, Spurlock G, McGuffin P, Mallet J, Nöthen MM, Gill M, Aschauer H, Nylander PO, Macciardi F, Owen MJ. Williams J, et al. Among authors: owen mj. Lancet. 1996 May 11;347(9011):1294-6. doi: 10.1016/s0140-6736(96)90939-3. Lancet. 1996. PMID: 8622505

7

Genetic studies on chromosome 12 in late-onset Alzheimer disease.

Wu WS, Holmans P, Wavrant-DeVrièze F, Shears S, Kehoe P, Crook R, Booth J, Williams N, Pérez-Tur J, Roehl K, Fenton I, Chartier-Harlin MC, Lovestone S, Williams J, Hutton M, Hardy J, Owen MJ, Goate A. Wu WS, et al. Among authors: owen mj. JAMA. 1998 Aug 19;280(7):619-22. doi: 10.1001/jama.280.7.619. JAMA. 1998. PMID: 9718053

8

The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

Kehoe PG, Williams H, Holmans P, Wilcock G, Cairns NJ, Neal J, Owen MJ. Kehoe PG, et al. Among authors: owen mj. J Med Genet. 1998 Dec;35(12):1034-5. doi: 10.1136/jmg.35.12.1034. J Med Genet. 1998. PMID: 9863603 Free PMC article.

9

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease.

Kehoe PG, Russ C, McIlory S, Williams H, Holmans P, Holmes C, Liolitsa D, Vahidassr D, Powell J, McGleenon B, Liddell M, Plomin R, Dynan K, Williams N, Neal J, Cairns NJ, Wilcock G, Passmore P, Lovestone S, Williams J, Owen MJ. Kehoe PG, et al. Among authors: owen mj. Nat Genet. 1999 Jan;21(1):71-2. doi: 10.1038/5009. Nat Genet. 1999. PMID: 9916793 No abstract available.

10

A full genome scan for late onset Alzheimer's disease.

Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, Fenton I, Spurlock G, Norton N, Williams H, Williams N, Lovestone S, Perez-Tur J, Hutton M, Chartier-Harlin MC, Shears S, Roehl K, Booth J, Van Voorst W, Ramic D, Williams J, Goate A, Hardy J, Owen MJ. Kehoe P, et al. Among authors: owen mj. Hum Mol Genet. 1999 Feb;8(2):237-45. doi: 10.1093/hmg/8.2.237. Hum Mol Genet. 1999. PMID: 9931331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,106 results

Search Page

Filters